FY15
Assets5.39
Net Worth2.64
Total Debt2.14
RevenueAnnualised basis2.69
EBITDAAnnualised basis0.03
PATAnnualised basis0.42
EBITDA Margin (%)1.12
At a glance
Updated 2026-09-04Ganga Pharmaceuticals is an IPO with an issue size of ₹1.54 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹1.54 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets5.93₹ Cr · +24.1% vs prior year
Net Worth3.26₹ Cr · +38.7% vs prior year
FY14
Assets5.14
Net Worth2.60
Total Debt2.07
RevenueAnnualised basis2.66
EBITDAAnnualised basis0.03
PATAnnualised basis0.37
EBITDA Margin (%)1.13
FY13
Assets4.78
Net Worth2.35
Total Debt1.64
RevenueAnnualised basis2.31
EBITDAAnnualised basis0.03
PATAnnualised basis0.36
EBITDA Margin (%)1.30
30-Sep-15
Assets5.93
Net Worth3.26
Total Debt2.00
RevenueAnnualised basis1.29
EBITDAAnnualised basis0.05
PATAnnualised basis0.24
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Ganga Pharmaceuticals IPO | — | 65.00 x | — | — |
| Shelter Pharma IPO | — | 8.40 x | — | — |
| Jeena Sikho IPO | — | 16.67 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-04.
IPO UPDATE ALERTS
Register for IPO Updates →Track Ganga Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.